ANZICS CTG Supported Study

ECMOCARD

Covid-19 Critical Care Consortium Observational Study Incorporating the Extra Corporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease

Study Description

In response to the COVID-19 outbreak and to assist in pandemic planning both locally and globally, a research collaborative has been assembled. The collaborative consists of investigators from the Asia-Pacific extracorporeal life support organization (APELSO) in collaboration with centers within the SPRINT-SARI and ISARIC Network. In Australia, this study will be also complemented through collaboration with the “National registry on the treatment and outcomes of patients requiring ECMO” (EXCEL Registry)

This study aims to describe clinical features; severity of pulmonary dysfunction; incidence of ICU admission, coagulatory and thrombotic derangement, cardiac dysfunction, neurological impact, kidney injury, use of mechanical ventilation, ECMO technical characteristics; duration of ECMO; complications; and survival of patients with COVID-19.

Steering Committee

Robert Bartlett, John Fraser, Gianluigi Li Bassi, Jacky Suen, Dan Brodie, Heidi Dalton, Mark Ogino, Shingo Ichiba, Antoni Torres, Carlos Luna, Giacomo Grasselli, Pauline Yeung, Eddy Fan, Carol Hodgson, John Laffey, Alyaa Elhazmi, Davide Chumello, Srinivas Murthy, Alistair Nicol, Aidan Burrell, Ian Yang, Eva Marwali, Muhammed Elhadi

Administering Institution

University of Queensland

Sample Size

20,000 patients

Reference

CTG2021-01, ACTRN12620000421932

Contact

John Fraser (email)